Fig. 6From: Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signalingMTHFD2 as a prognosis marker in ovarian cancer. A Overall survival (OS) curves calculated by Kaplan-Meier Plotter Analysis. B Progression Free Survival (PFS) curves calculated by Kaplan-Meier Plotter Analysis. C Expression of MTHFD2 in tumor (20 cases) and adjacent normal tissues (20 cases). D Kaplan-Meier curves based on MTHFD2 expression were drawn for overall survival in 35 patientsBack to article page